Literature DB >> 8692878

Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2.

S A Jones1, M Wolf, S Qin, C R Mackay, M Baggiolini.   

Abstract

Two monoclonal antibodies, anti-IL8R1 and anti-IL8R2, raised against both interleukin 8 receptors (IL-8R) of human neutrophils, IL-8R1 and IL-8R2, were used to study individual receptor functions after stimulation with IL-8, GRO alpha, or NAP-2. Efficacy and selectivity of the antibodies were tested in Jurkat cells transfected with cDNA coding for one or the other receptor. The binding of 125 I labeled IL-8 and IL-8-induced changes of the cytosolic free Ca2+ concentration were inhibited by anti-IL8RI in cells expressing IL-8R1 and by anti-IL8R2 in cells expressing IL-8R2. In human neutrophils, release of elastase was observed after stimulation with IL-8 or GRO alpha. The response to IL-8 was inhibited slightly by anti-IL8R1 and more substantially when both monoclonal antibodies were present, while the response to GRO alpha was inhibited by anti-IL8R2 but was not affected by anti-IL8R1. These results indicate that both IL-8 receptors can signal independently for granule enzyme release. Superoxide production, a measure of the respiratory burst, was obtained with increasing concentrations of IL-8 with maximum effects at 25 to 50 nM, but no response was observed upon challenge with GRO alpha or NAP-2 up to 1000 nM. The superoxide production induced by IL-8 was inhibited by anti-IL8R1, but was not affected by anti-IL8R2. Stimulation of neutrophils with IL-8, in contrast to GRO alpha or NAP-2, also elicited phospholipase D activity. The effect of IL-8 was again inhibited by anti-IL-8R1 but not by anti-IL8R2, indicating that this response, like the respiratory burst, was mediated by IL-8R1. Taken together, our results show that IL-8R1 and IL-8R2 are functionally different. Responses, such as cytosolic free Ca2+ changes and the release of granule enzymes, are mediated through both receptors, whereas the respiratory burst and the activation of phospholipase D depend exclusively on stimulation through IL-8R1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692878      PMCID: PMC39086          DOI: 10.1073/pnas.93.13.6682

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Two distinct Gi-proteins mediate formyl peptide receptor signal transduction in human leukemia (HL-60) cells.

Authors:  P Gierschik; D Sidiropoulos; K H Jakobs
Journal:  J Biol Chem       Date:  1989-12-25       Impact factor: 5.157

2.  IL-8 induces neutrophil chemotaxis predominantly via type I IL-8 receptors.

Authors:  M E Hammond; G R Lapointe; P H Feucht; S Hilt; C A Gallegos; C A Gordon; M A Giedlin; G Mullenbach; P Tekamp-Olson
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

3.  Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide agonist.

Authors:  M Thelen; P Peveri; P Kernen; V von Tscharner; A Walz; M Baggiolini
Journal:  FASEB J       Date:  1988-08       Impact factor: 5.191

4.  Phospholipase D catalyzes phospholipid metabolism in chemotactic peptide-stimulated HL-60 granulocytes.

Authors:  J K Pai; M I Siegel; R W Egan; M M Billah
Journal:  J Biol Chem       Date:  1988-09-05       Impact factor: 5.157

5.  Chemiluminescence detection of H2O2 produced by human neutrophils during the respiratory burst.

Authors:  M P Wymann; V von Tscharner; D A Deranleau; M Baggiolini
Journal:  Anal Biochem       Date:  1987-09       Impact factor: 3.365

6.  Activation of NADPH-dependent superoxide production in plasma membrane extracts of pig neutrophils by phosphatidic acid.

Authors:  P Bellavite; F Corso; S Dusi; M Grzeskowiak; V Della-Bianca; F Rossi
Journal:  J Biol Chem       Date:  1988-06-15       Impact factor: 5.157

7.  Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor.

Authors:  A Chuntharapai; K J Kim
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

8.  Ion channels in human neutrophils activated by a rise in free cytosolic calcium concentration.

Authors:  V von Tscharner; B Prod'hom; M Baggiolini; H Reuter
Journal:  Nature       Date:  1986 Nov 27-Dec 3       Impact factor: 49.962

9.  A novel neutrophil-activating factor produced by human mononuclear phagocytes.

Authors:  P Peveri; A Walz; B Dewald; M Baggiolini
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

10.  Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils.

Authors:  A Walz; B Dewald; V von Tscharner; M Baggiolini
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

View more
  51 in total

1.  Impaired interleukin-8-induced degranulation of polymorphonuclear neutrophils from human immunodeficiency virus type 1-infected individuals.

Authors:  S Meddows-Taylor; D J Martin; C T Tiemessen
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

Review 2.  Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring.

Authors:  Peter Adam Rees; Nicholas Stuart Greaves; Mohamed Baguneid; Ardeshir Bayat
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

Review 3.  Chemokines as Therapeutic Targets to Improve Healing Efficiency of Chronic Wounds.

Authors:  Latha Satish
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

Review 4.  Chemokine Regulation of Neutrophil Infiltration of Skin Wounds.

Authors:  Yingjun Su; Ann Richmond
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

5.  Interleukin-8-derived peptide has antibacterial activity.

Authors:  Ase Björstad; Huamei Fu; Anna Karlsson; Claes Dahlgren; Johan Bylund
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

6.  Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer.

Authors:  Mohd W Nasser; Sandeep K Raghuwanshi; Delores J Grant; Venkatakrishna R Jala; Krishna Rajarathnam; Ricardo M Richardson
Journal:  J Immunol       Date:  2009-08-10       Impact factor: 5.422

Review 7.  Platelet-derived chemokines: pathophysiology and therapeutic aspects.

Authors:  Hans-Dieter Flad; Ernst Brandt
Journal:  Cell Mol Life Sci       Date:  2010-03-07       Impact factor: 9.261

8.  Blastomyces dermatitidis serine protease dipeptidyl peptidase IVA (DppIVA) cleaves ELR+ CXC chemokines altering their effects on neutrophils.

Authors:  Jenna Lorenzini; J Scott Fites; Jeniel Nett; Bruce S Klein
Journal:  Cell Microbiol       Date:  2017-05-30       Impact factor: 3.715

9.  CXCR1 Regulates Pulmonary Anti-Pseudomonas Host Defense.

Authors:  M Carevic; H Öz; K Fuchs; J Laval; C Schroth; N Frey; A Hector; T Bilich; M Haug; A Schmidt; S E Autenrieth; K Bucher; S Beer-Hammer; A Gaggar; M Kneilling; C Benarafa; J L Gao; P M Murphy; S Schwarz; B Moepps; D Hartl
Journal:  J Innate Immun       Date:  2016-03-08       Impact factor: 7.349

Review 10.  CXC chemokines and their receptors: a case for a significant biological role in cutaneous wound healing.

Authors:  Snjezana Zaja-Milatovic; Ann Richmond
Journal:  Histol Histopathol       Date:  2008-11       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.